Atreca (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- August 17, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Company Description
- Atreca is a privately held biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. We are able to measure and analyze the structure of clinically relevant immune responses to identify the antibodies, T cell receptors, and targets that are key to successful treatment outcomes.
- Market
- Therapeutics
- Location
- Redwood City, California, USA
- Coinvestors
- Cormorant Asset Management, Wellington Management Company